I think they said there was some stocking. Regardless of the market share everyone is being hit right now. I listened to 2 ccs last 2 days both mentioned it. Gsk said ovarian debulking down 20 percent (good sales of PARP despite this). SGEN HL diagnoses down accounting for dip in adcetris So have to think a scenario like this with asymptomatic patients covid effects are going to be even more pronounced
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.